Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Similar documents
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

How do we treat migraine? New SIGN Guidelines

Understanding. Migraine. Amy, diagnosed in 1989, with her family.

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Migraine much more than just a headache

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

MIGRAINE A MYSTERY HEADACHE

Management of headache

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

Faculty/Presenter Disclosure

Specific Objectives A. Topics to be lectured and discussed at the plenary sessions

Outpatient Headache Care Guideline

Proposed Project Scope. OPTIMAL USE OnabotulinumtoxinA for the Prevention of Chronic Migraine Clinical Evidence, Policies and Practice

Update on Diagnosis and Management of Migraines

Disclosures. Objectives 6/2/2017

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

UCNS Course A Review of ICHD-3b

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

What is the Effectiveness of OnabotulinumtoxinA (Botox ) in Reducing the Number of Chronic Migraines (CM) in Patients Years Old?

Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Headache Pain Generators

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Dubai Standards of Care (Migraine)

Painless, progressive weakness Could this be Motor Neurone Disease?

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

David W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA

Strategies in Migraine Care

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

A Q&A with N1-Headache users

Daniel Kassicieh, DO, FAAN

Mark W. Green, MD, FAAN

ADVANCES IN MIGRAINE MANAGEMENT

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

Migraine Types and Triggering Factors in Children

Aleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 5/18/17 SECTION: DRUGS LAST REVIEW DATE: 5/17/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Stuart Weatherby Consultant Neurologist Derriford Hospital. Plymouth

This policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc.

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

HEADACHE. Dr Nick Pendleton. September Headache

25/09/2018 HEADACHE. Dr Nick Pendleton

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Prednisone vs. placebo in withdrawal therapy following medication overuse headache

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Recognition and treatment of medication overuse headache

Disclosures. Triptans for Kids 5/16/13

UNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition

10/19/2018. Disclosures MIGRAINE PROPHYLAXIS. Objectives. Definitions Slide. What do you think the aooe stands for at the end of erenumab-aooe?

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

Is Yoga an Effective Treatment for Reducing the Frequency of Episodic Migraine?

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Is Topiramate Effective in Preventing Pediatric Migraines?

HEADACHE: Types, Tips & Treatment Suggestions

Migraine: Developing Drugs for Acute Treatment Guidance for Industry

Headache. Karen Thaxter

Maternity. Migraine in pregnancy Information for women

Headaches in Pregnancy Before, During, and After

By Nathan Hall Associate Editor

July 2012 Target Population. Adult patients 18 years or older in primary care settings.

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital

11/10/2017. THE BRIDGE Course Objectives. THE BRIDGE Course Objectives

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

ONZETRA XSAIL (sumatriptan) nasal powder

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention

Migraine Management. Roger Cady, MD Headache Care Center Springfield, MO

Chronic Daily Headaches

Managing Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital

6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond

Subject: CGRP Inhibitors

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

Migraine and hormonal contraceptives

WHY IS MIGRAINE IMPORTANT

Migraine Treatment What you need to know

NEXT GENERATION MIGRAINE THERAPIES. Saturday, April 6, 2019 Sheraton San Diego Hotel & Marina-Bay Tower San Diego, California

Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention

Subject: Aimovig (erenumab) Original Effective Date: 7/10/2018. Policy Number: MCP-320. Revision Date(s):

Treatment Of Medication. Overuse Headache

Migraine By Oliver Sacks READ ONLINE

Corporate Medical Policy

Transcription:

Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary

Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical Trials Support, Allergan and Amgen Speakers Bureau/Honoraria: Allergan, Amgen, Serono. Consulting Fees: Allergan, Amgen Other: None

What is Migraine? Migraine is an inherited, disabling neurological condition that leads to attacks of head pain, sensitivity to the environment, and other neurological symptoms. Migraine is a genetic condition, but many factors over a person s lifetime affect how frequent and severe migraine can be. http://www.americanmigrainefoundation.org

Overall, the one year point prevalence of migraine is 12 % in the adult general population 4

Prevalence of Chronic Migraine in the United States Chronic migraine accounts for 8 % of all migraine cases, 1 % of the general population Schwedt TJ BMJ 2014; 348: g1416

Diagnosis and Management of Chronic Migraine is Complex Chronic migraine must be differentiated from secondary headaches causing frequent or daily headache There is often no single simple solution to the pain and disability faced by patients Many patients will need: 1. Lifestyle and trigger advice 2. Behavioural management (e.g. stress management skills, relaxation skills etc.) 3. Acute pharmacological treatment 4. Prophylactic pharmacological treatment 5. Management of acute medication overuse

Diagnosis

8 Headache Case A 30 year old female has a history of unilateral headaches starting at age 20 that throbbed, lasted 36 hours untreated, and had significant associated nausea. For two years she has had headache on about 23 days a month. These are often bilateral and of moderate severity. On about 12 days a month she has more severe unilateral throbbing headache. She is taking sumatriptan on at least 12 days a month, and acetaminophen with codeine on 8 additional days a month.

9 Case 2. Her headache disorder is most correctly classified as: a. b. c. d. e. Medication overuse headache Chronic migraine Chronic tension-type headache Both chronic migraine and medication overuse headache Mixed headache with both migraine and tension-type headache

Diagnostic Criteria

11 Criteria for Chronic Migraine A. Headache (tension-type and / or migraine) on 15 days per month for at least 3 months. B. Has had at least 5 attacks of migraine with or without aura. C. On 8days per month for 3 months has fulfilled criteria for migraine, or was believed to be migraine and treated successfully with a triptan or ergot. D. Not better accounted for by another diagnosis. ICHD-3 Cephalalgia 2013; 33(9): 627-808.

12 Migraine Without Aura At least 5 attacks with: 4-72 hour duration 2 of: unilateral location pulsating pain moderate or severe intensity aggravation by or causing avoidance of physical activity during attack 1 of: nausea and/or vomiting photo and phonophobia No other cause apparent ICHD-3Cephalalgia 2013; 33(9): 627-808

How is Chronic Migraine defined in ICHD-3 beta? Changes from ICHD-2 Chronic Migraine diagnosis excludes chronic tension-type headache diagnosis 8 migraine days a month may be with or without aura Patients who meet criteria for both Chronic Migraine and medication-overuse headache should be diagnosed with both Headache Classification Committee of the International Headache Society (IHS). Cephalalgia. 2013;33:629-808.

Diagnostic Algorithm for Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):1471-1481.

http://www.topalbertadoctors.org/cpgs/?sid=65&cpg_cats=88

Diagnostic Algorithm for Chronic Migraine (Continued) Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Management of Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Becker WJ, Headache 2017 Oct;57(9):1471-1481.

The Headache Diary Record days with headache and headache intensity Record acute medication use, and the response to these medications Record prophylactic medication use Keep a record of occurrence of potential triggers Record menstrual cycle

Management of Medication Overuse Headache Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Case 1: 58 year old male Migraine since 12 years of age Chronic daily headache for at least ten years prior to being seen, associated with daily use of acetaminophen and ibuprofen On amitriptyline 25 mg daily What is the single most important management strategy at this point?

Provide information of necessary limits to avoid risk of medication overuse headache: -Use of triptans and combination analgesics on < 10 days a month -Use of acetaminophen or NSAIDs on < 15 days a month or more.

Medication Overuse Headache: Headache days per month: Brief advice intervention versus usual care Intervention: Information and advice to stop medication overuse by primary care physician Double-blind Randomized Controlled Trial Mean duration of Medication overuse: 8 years Baseline: dotted lines; 3 month follow up: solid lines

Medication Overuse Headache Medication days: Brief advice intervention vs usual care Intervention: Information And advice to stop medication Overuse by primary care physician Double-blind Randomized Controlled Trial Mean duration of Medication overuse: 8 years Baseline: dotted lines; 3 month follow up: solid lines

Management of Medication Overuse Headache (Continued)

Systematic Review of Medication Overuse Headache: Conclusions Adding preventive medications to early discontinuation of overused medications leads to a better outcome than early discontinuation alone. Preventive medications alone may have some utility in medication overuse headache Chiang C-C, et al Cephalalgia 2016; 36(4): 371-386

Standard of Care Standard of Care for patients with chronic migraine and medication overuse headache: 1. Stop overused medication, but combine with: - Preventive medications and / or biobehavioural therapy Chiang C-C, et al Cephalalgia 2016; 36(4): 371-386

Treatment of medication overuse headache Patient education Stop medication overuse Start prophylactic Treat severe attacks Patient follow-up 29

Management of Chronic Migraine (Continued) Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Prescribing a Migraine Preventive Medication Educate the patient that the medication must be taken daily Ensure the patient has realistic expectations of benefit: 1. Headache attacks will not be abolished completely 2. A reduction of headache frequency of 50% is considered worthwhile 3. In chronic migraine, even lesser reductions in frequency, or reductions in intensity may make prophylaxis worth while. 4. It may take 4 to 8 weeks for significant benefit to occur, and this may increase with time Increase the dose until the medication is effective, dose limiting side effects occur, or a target dose is reached Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Schwedt TJ BMJ 2014; 348: g1416 *Other drugs With evidence fo Efficacy in Episodic migraine Are also used clinically

Motto: Start Low and go Slow Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Management of Chronic Migraine (Continued) Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Use of OnabotulinumtoxinA in Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):1471-1481.

OnabotulinumtoxinA mode of action OnabotulinumtoxinA blocks release of glutamate and peptides from nociceptive nerve endings. Sensory neurons not only take up local onabot, but moves it via fast axonal transport to their central terminals. Onabot may regulate cell surface expression of a number of receptors and ion channels (TRPV1, AMPA, etc). Some (many) nociceptive nerve fibers have branches both on the meninges and in the extracranial structures. Ramachandran R et al B J Pharmacol 2014; 171: 4177-4192 38

Roles of Primary Care Provider In Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Referral of the Chronic Migraine Patient By the Primary Care Provider And Role After Referral Becker WJ, Headache 2017 Oct;57(9):1471-1481.

Factors associated with reversion of Chronic migraine to episodic migraine 1. Lower baseline headache frequency (15 19 vs 25 21 days per month) 2. Adherence to prophylactic drugs 3. Withdrawal of overused acute drugs 4. Physical exercise 5. Correction of sleep disturbances (Calhoun AH Headache. 2007 Sep;47(8):1178-83)

The Diagnosis and Management of Chronic Migraine in Primary Care The primary care physician is critical in identifying patients with chronic migraine and initiating therapy. Initiation of therapy should include both pharmacological and nonpharmacological approaches. In Canada, the availability of medical resources and the high prevalence of chronic migraine dictates that the role of the primary care physician must be significant in order to help patients with chronic migraine